Scoreflex TRIO - Scoring PTCA Catheter

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 210 participants.

Also called NCT05929313

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 210 participants (enrolled count) (from the registry)
Sponsor
  • OrbusNeich Registry lists this organization as the lead sponsor
Registry
  • NCT NCT05929313
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05929313. Randomized; no masking; primary purpose treatment. Start 2023-04-27 (actual); primary completion 2024-04-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Scoreflex TRIO - Scoring PTCA Catheter
Condition
Coronary Arteriosclerosis
Intervention (Device)
OrbusNeich Scoreflex TRIO
Intervention (Device)
OrbusNeich Scoreflex NC
Lead sponsor
OrbusNeich (class: industry)
Collaborator
CCRC Medtech (Shanghai) Co., Ltd. (class: not stated)

Record details

Record id
cardio:ct-nct05929313
Content hash
6699ad69fd21ca2699c26410aa5dca8e8f431d7d43b782bc8867f623974b345b